In light of debate within American society on the topic of stem cell research, the JCPA adopted a resolution on therapeutic cloning research in 2004.  The following clarifies the scientific content of that policy’s action recommendations:

 

The community relations field should:

  1. Research using embryonic stem cells including those developed through Somatic Cell Nuclear Transfer (SCNT);
  2. Government funding for such research;
  3. Efforts by the scientific community to develop regulations and monitor those using SCNT technology;
  4. Appropriate legislative actions consistent with the above objectives, including legislation that encourages the development of new stem cell lines in addition to the existing stem cell lines already approved for funding by the federal government;
  5. The creation of a fully funded and empowered oversight body comprising of scientists and ethicists to monitor this research, paying special attention to ensuring that the research is restricted to stem cells of very early embryonic development, prior to implantation in a uterus.
 
Share

Next Up:

Court Stripping

Take Action Donate

October 16, 2025

Antisemitism and Democracy

October 13, 2025

JCPA Welcomes Israeli Hostages Back Home

October 9, 2025

Director of Communications

October 6, 2025

JCPA Marks Sukkot Amid Joy and Pain Two Years After October 7th Attacks

October 3, 2025

JCPA Heartbroken by Deadly Attack on Manchester Synagogue on Yom Kippur

October 1, 2025

JCPA in New York Times on Social Media Polarization

September 29, 2025

X-posed: Antisemitism on X

September 29, 2025

X-posed: Antisemitism on X

September 29, 2025

New Report Exposes X/Twitter as One of the Most Dangerous Vehicles in History for Spreading Antisemitism

September 29, 2025

CNN: Musk’s X is ‘go-to platform’ for antisemitism, study finds